Loading...
UK Trademark — IPO
KISIMA
Application UK00915306194 · Registered
Quick Facts
| Application Number | UK00915306194 |
| Status | Registered |
| Owner | AMAL Therapeutics SA |
| Filed | 2016-04-06 |
| Registered | 2017-04-28 |
| Renewal Due | 2036-04-06 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. KISIMA is currently a registered UK trademark, with renewal due on 2036-04-06. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 1 — Chemicals
Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins, in particular for industrial and scientific purposes; biological, micro-biological and biochemical products for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific purposes; peptide substrates for scientific purposes; proteins for use in science, industry and manufacture; biological preparations; reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes; nucleic acids, in particular recombinant nucleic acids; nucleic acids for scientific purposes; nucleic acid sequences; biological active peptides; antisera for scientific and industrial purposes; all above other than for medical and veterinary use.
Class 5 — Pharmaceuticals
Proteins, peptides, modified peptides; proteins, derivatives of peptides and proteins as well as protein- and peptide-pools for medical and pharmaceutical purposes; diagnostic preparations; cells for medical purposes; pharmaceutical preparations and compositions for the treatment and prevention of cancer; recombinant nucleic acids for medical use; nucleic acids for medical purposes; nucleic acid sequences and proteins for medical and diagnostic purposes; kits containing proteins, peptides, modified peptides and proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes; all the aforementioned goods in the form of vaccines, and/or for use in the field of oncology, infectious diseases and/or autoimmune diseases, and/or for the treatment of and/or the prevention of cancer diseases, infectious diseases and/or autoimmune diseases.
Class 42 — Scientific & IT Services
Scientific and technological services and research and design relating thereto; Industrial analysis and research services; research and development services all relating to science; medical and pharmaceutical research and development services; biological and clinical research and development services; research and development services all relating to industry; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical, biochemical, medical or pharmaceutical research; medical and pharmacological research services; medical research; scientific research for medical purposes; laboratory research services in the field of protein, peptide and molecular biology; provision of information and data relating to medical and scientific research and development; medical and pharmaceutical product development and evaluation; Research and development services for the pharmaceutical industry; Information technology services for the pharmaceutical and healthcare industries.
Class 44 — Medical & Beauty Services
Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services; Pharmaceutical services; Medical information.
Timeline
- Filed: 2016-04-06
- Registered: 2017-04-28
- Renewal due: 2036-04-06
About This Trademark
'KISIMA' is a registered trademark on the UK IPO register, owned by AMAL Therapeutics SA. The application (UK00915306194) was filed on 6 April 2016 and registered on 28 April 2017. The registration is set to expire on 6 April 2036.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by N. J. Akers & Co..
Frequently Asked Questions
Who owns UK trademark UK00915306194 ('KISIMA')?
UK trademark UK00915306194 for the mark 'KISIMA' in Class 1, 5, 42, 44 is recorded on the UK IPO register as owned by AMAL Therapeutics SA. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00915306194 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00915306194 for the mark 'KISIMA' as registered.
Which Nice classes is UK trademark UK00915306194 registered under?
UK trademark UK00915306194 for the mark 'KISIMA' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 1: Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins, in particular for industrial and scientific purposes; biological, micro-biological and biochemical products for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, mo…
When was UK trademark UK00915306194 filed?
UK trademark UK00915306194 for the mark 'KISIMA' was filed at the UK IPO on 6 April 2016 and registered on 28 April 2017.
When does UK trademark UK00915306194 need to be renewed?
UK trademark UK00915306194 for the mark 'KISIMA' is currently recorded as valid until 6 April 2036, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00915306194?
N. J. Akers & Co. is listed as the attorney / representative of record for UK trademark UK00915306194 for the mark 'KISIMA' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "KISIMA" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| KISIMASame applicant | 87149001 | 710 | 2016-08-24 |
| NEVER ALONE KISIMA INNITCHUNA | 86456612 | 606 | 2014-11-17 |
| NEVER ALONE KISIMA INNITCHUNA | 86456713 | 606 | 2014-11-17 |
| NEVER ALONE KISIMA INNITCHUNA | 86456716 | 606 | 2014-11-17 |
| NEVER ALONE (KISIMA INNITCHUNA) | 86319173 | 606 | 2014-06-24 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.